To explore the mechanism by which morphine promotes the incidence of HIV infection, we evaluated the regulatory role of morphine on the interferon-␥ (IFN-␥) promoter in activated T cells from wild type and -opioid receptor knockout mice. Our results show that morphine inhibited anti-CD3/CD28-stimulated IFN-␥ promoter activity in a dose-dependent manner. Chronic morphine treatment of T cells increased intracellular cAMP. To evaluate the role of cAMP in morphine's modulatory function, the effects of dibutyryl cyclic AMP and forskolin were investigated. Both dibutyryl cyclic AMP and forskolin treatment inhibited IFN-␥ promoter activity. Treatment with pertussis toxin, but not with a protein kinase A inhibitor, antagonized morphine's inhibitory effects. Morphine inhibited phosphorylation of ERK1/2 and p38 MAPK; in addition, morphine treatment in the presence of either ERK1/2 or p38 MAPK inhibitor (PD98059 or SB203580) resulted in an additive inhibition of IFN-␥ promoter activity. The transcription factor activator protein-1, NF-B, and nuclear factor of activated T cells (NFAT) were negatively regulated by morphine. Overexpression of NF-B p65 rescued the inhibitory effect of morphine on IFN-␥ promoter activity. However, only when NFATc1 was co-overexpressed with c-fos was the inhibitory effect of morphine on IFN-␥ promoter counteracted. The inhibitory effects of morphine were not observed in T cells obtained from -opioid receptor knockout mice, suggesting that morphine modulation of IFN-␥ promoter activity is mediated through the -opioid receptor. In summary, our data indicate that morphine modulation of IFN-␥ promoter activity is mediated through two distinct cAMP-dependent pathways, the NF-B signaling pathway and the ERK1/2, p38 MAPK, AP-1/NFAT pathway.Chronic opioid abusers have been known to experience higher incidence of infectious diseases. It is now well established that opioid use and abuse promotes human immunodeficiency virus infection and disease progression (1, 2). IFN-␥ 1 is a cytokine that modulates all phases of immune processes. It is produced predominantly in activated T cells and large granular lymphocytes as well as natural killer cells (3). IFN-␥ plays a central role in host resistance to infection, notably viral infection (4). Previous studies, including our own, have shown that morphine use and abuse results in the inhibition of IFN-␥ production and may explain why a higher incidence of human immunodeficiency virus and other viral infections is observed in the drug abuse population (5-8). Although morphine's inhibitory effects on IFN-␥ production are well known, the mechanisms by which morphine causes this suppressive effect have not been fully elucidated. In neuronal cells, morphine binds to a G protein-coupled -opioid receptor to induce analgesia (9, 10). Activation of the -opioid receptor leads to regulation of several intracellular effectors, such as modulation of adenylyl cyclase activity (11). Cyclic AMP (cAMP) is a negative regulator of T cell activation. Increased intracellular cAMP conc...